These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 6245807)
1. Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture. Baylin SB; Abeloff MD; Goodwin G; Carney DN; Gazdar AF Cancer Res; 1980 Jun; 40(6):1990-4. PubMed ID: 6245807 [TBL] [Abstract][Full Text] [Related]
2. Effects of dibutyryl cyclic adenosine 3':5'-monophosphate on the growth of cultured human small-cell lung carcinoma and the specific cellular activity of L-dopa decarboxylase. Francis J; Thompson R; Bernal SD; Luk GD; Baylin SB Cancer Res; 1983 Feb; 43(2):639-45. PubMed ID: 6293702 [TBL] [Abstract][Full Text] [Related]
3. Endocrine-related biochemistry in the spectrum of human lung carcinoma. Berger CL; Goodwin G; Mendelsohn G; Eggleston JC; Abeloff MD; Aisner S; Baylin SB J Clin Endocrinol Metab; 1981 Aug; 53(2):422-9. PubMed ID: 6114110 [TBL] [Abstract][Full Text] [Related]
4. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288 [TBL] [Abstract][Full Text] [Related]
5. Aromatic L-amino acid decarboxylase activities in human lung tissues: comparison between normal lung and lung carcinomas. Nagatsu T; Ichinose H; Kojima K; Kameya T; Shimase J; Kodama T; Shimosato Y Biochem Med; 1985 Aug; 34(1):52-9. PubMed ID: 2996509 [TBL] [Abstract][Full Text] [Related]
6. Elevated histaminase (diamine oxidase) activity in small-cell carcinoma of the lung. Baylin SB; Abeloff MD; Wieman KC; Tomford JW; Ettinger DS N Engl J Med; 1975 Dec; 293(25):1286-90. PubMed ID: 171575 [TBL] [Abstract][Full Text] [Related]
7. Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications. Baylin SB; Weisburger WR; Eggleston JC; Mendelsohn G; Beaven MA; Abeloff MD; Ettinger DS N Engl J Med; 1978 Jul; 299(3):105-10. PubMed ID: 26872 [TBL] [Abstract][Full Text] [Related]
8. Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. Gazdar AF; Zweig MH; Carney DN; Van Steirteghen AC; Baylin SB; Minna JD Cancer Res; 1981 Jul; 41(7):2773-7. PubMed ID: 6265067 [TBL] [Abstract][Full Text] [Related]
9. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Gilbert JA; Frederick LM; Ames MM Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255 [TBL] [Abstract][Full Text] [Related]
10. Hydrogen peroxide degradation and selective carbidopa-induced cytotoxicity against human tumor lines. Gilbert JA; Frederick LM; Pobst LJ; Ames MM Biochem Pharmacol; 2005 Apr; 69(8):1159-66. PubMed ID: 15794936 [TBL] [Abstract][Full Text] [Related]
11. Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines. Levitt ML; Gazdar AF; Oie HK; Schuller H; Thacher SM Cancer Res; 1990 Jan; 50(1):120-8. PubMed ID: 1967140 [TBL] [Abstract][Full Text] [Related]
12. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200 [TBL] [Abstract][Full Text] [Related]
14. IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. Lan MS; Russell EK; Lu J; Johnson BE; Notkins AL Cancer Res; 1993 Sep; 53(18):4169-71. PubMed ID: 8364910 [TBL] [Abstract][Full Text] [Related]
15. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma. Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716 [TBL] [Abstract][Full Text] [Related]
16. Levels of histaminase and L-DOPA decarboxylase activity in the transition from C-cell hyperplasia to familial medullary thyroid carcinoma. Baylin SB; Mendelsohn G; Weisburger WR; Gann DS; Eggleston JC Cancer; 1979 Oct; 44(4):1315-21. PubMed ID: 115572 [TBL] [Abstract][Full Text] [Related]
17. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320 [TBL] [Abstract][Full Text] [Related]
18. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Carney DN; Gazdar AF; Bepler G; Guccion JG; Marangos PJ; Moody TW; Zweig MH; Minna JD Cancer Res; 1985 Jun; 45(6):2913-23. PubMed ID: 2985257 [TBL] [Abstract][Full Text] [Related]
19. The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. Lippman SM; Mendelsohn G; Trump DL; Wells SA; Baylin SB J Clin Endocrinol Metab; 1982 Feb; 54(2):233-40. PubMed ID: 6798062 [TBL] [Abstract][Full Text] [Related]
20. Differential behavior of human bronchial carcinoma cells in culture. Klein JC; Zurcher C; van Bekkum DW Cancer Res; 1987 Jun; 47(12):3251-8. PubMed ID: 3034407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]